Zeng Tian, Zheng Zhikang, Qian Honglan, Liu Lirong, Shi Xiaowei, Shao Yanping, Huang Zhaohao, Li Rumeng, Wen Bingbing, Han Qingmei, Feng Qiutian, Tu Lingrong, Bao Xiaojing, Tong Hongyan, Jin Jie, Huang Jian
Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
Department of Hematology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, People's Republic of China.
J Inflamm Res. 2025 Jul 15;18:9229-9242. doi: 10.2147/JIR.S527476. eCollection 2025.
Myelofibrosis (MF) is a rare myeloproliferative neoplasm (MPN) characterized by significant mortality and limited predictive biomarkers. The red cell distribution width to albumin ratio (RAR), a novel biomarker indicative of inflammation, has emerged as a strong prognostic indicator in the general population but remains unexplored in MF.
We retrospectively enrolled 504 consecutive MF patients from 7 hematological centers over a 10-year period. Multivariate Cox regressions were performed to assess the prognostic value of the RAR. Kaplan-Meier and restricted cubic splines (RCS) analyses were further performed to examine the associations between RAR and outcomes. Interaction and subgroup analyses were conducted to explore potential effect modifiers. We developed a predictive nomogram combining RAR and DIPSS-plus, with its incremental improvements assessed by discrimination and calibration metrics.
Patients who experienced leukemic transformation and death had significantly higher RAR levels. RAR remained an independent predictor of poor survival (adjusted HR: 1.58, 95% CI: 1.36-1.85). RCS further suggested a positive non-linear association between RAR and overall survival. Adding RAR to DIPSS-plus score significantly improved prediction accuracy, as shown by an increased C-index from 0.709 to 0.762, a net reclassification improvement (31.1%, = 0.004), and an integrated discrimination improvement (6.80%, < 0.001). The refined model also demonstrated a significantly improved goodness of fit, as evidenced by a likelihood ratio test ( < 0.001) and reductions in AIC and BIC values.
This large, multi-center cohort study is the first to reveal the prognostic significance of RAR in MF. The modified predictive nomogram combining DIPSS-plus score and RAR enhances prognostic discrimination and calibration, providing a simple yet cost-effective tool for refined risk stratification, especially in resource-limited settings.
骨髓纤维化(MF)是一种罕见的骨髓增殖性肿瘤(MPN),死亡率高且预测性生物标志物有限。红细胞分布宽度与白蛋白比值(RAR)是一种新的炎症指示生物标志物,已成为一般人群中强有力的预后指标,但在MF中尚未得到探索。
我们回顾性纳入了7个血液学中心10年间连续的504例MF患者。进行多变量Cox回归以评估RAR的预后价值。进一步进行Kaplan-Meier和限制性立方样条(RCS)分析,以检验RAR与预后之间的关联。进行交互作用和亚组分析以探索潜在的效应修饰因素。我们开发了一种结合RAR和DIPSS-plus的预测列线图,并通过区分度和校准指标评估其增量改进。
发生白血病转化和死亡的患者RAR水平显著更高。RAR仍然是生存不良的独立预测因素(调整后的风险比:1.58,95%置信区间:1.36-1.85)。RCS进一步表明RAR与总生存之间存在正非线性关联。将RAR添加到DIPSS-plus评分中显著提高了预测准确性,C指数从0.709增加到0.762,净重新分类改善(31.1%,P = 0.004),综合判别改善(6.80%,P < 0.001)表明了这一点。改进后的模型还显示拟合优度显著提高,似然比检验(P < 0.001)以及AIC和BIC值降低证明了这一点。
这项大型多中心队列研究首次揭示了RAR在MF中的预后意义。结合DIPSS-plus评分和RAR的改良预测列线图增强了预后区分度和校准,为精确的风险分层提供了一种简单且经济高效的工具,尤其是在资源有限的环境中。